The incidence of end-stage renal failure in 17 years of heart transplantation: A single center experience

Journal of Heart and Lung Transplantation

Volumn 21, Issue 6, 2002, Pages 651-657

  Satchithananda, Duwarakan K ^a   Parameshwar, Jayan ^a   Sharples, Linda ^b   Taylor, Gordon J ^c   McNeil, Keith ^a   Wallwork, John ^a   Large, Stephen R ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Bath Royal Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CREATINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0036285575     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00411-9     Document Type: Article

References (16)

1. Cyclosporine-associated chronic nephropathy
2. Cyclosporine nephrotoxicity in cardiac transplant recipients. One to seven year follow up in 228 patients
3. Cyclosporine A in cardiac transplantation: Medium-term results in 62 patients
4. Cyclosporine-associated end-stage nephropathy after cardiac transplantation
5. Cyclosporine-induced chronic nephropathy: An obliterative microvascular renal injury
6. The case against the indefinite use of cyclosporine
7. The long term course of cyclosporine-associated chronic nephropathy
8. Chronic cyclosporine nephropathy: The Achilles heel of immunosuppressive therapy
9. Early and late forms of cyclosporine nephrotoxicity: Studies in cardiac transplant recipients
10. Long-term nephrotoxicity of low doses of cyclosporine in heart transplant recipients
11. Progressive renal insufficiency following cardiac transplantation: Cyclosporine, lipids and hypertension
12. Time course of the decline in renal function in cyclosporine-treated heart transplant recipients
13. Predictors and evolution of renal function during 9 years following heart transplantation
14. Early detection of heart transplant patients with increased risk of cyclosporine nephrotoxicity
15. Survival of heart transplant recipients with cyclosporine-induced renal insufficiency
16. The management of cyclosporine-induced nephrotoxicity after cardiac transplantation